In our study, immunohistochemistry staining did not reveal differences in PD-L1 and PD-L2 expression in treatment-naïve p16-positive compared to p16-negative HNSCC tissue samples (Figure 1), which may be due to the smaller sample size. The gene discussed is PDCD1LG2; the disease is head and neck squamous cell carcinoma.